1Valdivia 1, Campodonico 1, tapia A et al. Effect s of tibolone and continuous combined hormone therapy on mammographic breast density and breast histechemical markers in post - menopausal women. Fertil Stefil, 2004, 81 (3) :617
3Kroiss R, Fentiman IS, Helmond FA et al. The effect of ti2 bolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double blind, placebocont rolled trial, BJOG, 2005, 112 (2):228
5Palomba S, Di Carlo C, Morelli M et al. Effect of tibolone on breast symptoms resulting from Postmenopausal hormone replacement therapy. Matufitas, 2003, 45 (4): 267
6Samsioe G. Urogenital aging-a hidden problem[ J]. Am J Obstet Gynecol, 1998,178 ( 5 ) : S245 - S249.
7Manonai J, Theppisai U, Suthutvoravut S, et al. The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women : a comparative study [ J ]. J Obstet Gynaecol Res,2001,27 (5) :255 - 260.
8Cardozo L, Bachmann G, McClish D, et al. Meta-analysis of estrogen therapy in the management of urogenital atrophy in post menopausal woman : second report of the Hormones and Urogenital Therapy Committee[ J]. Obstet Gynecol,1998,92(4 Pt 2) :722 -727.
9Bezirtzoglou E, Voidarou CH,Papadaki A,et al.Hormone therapy altersthe composition of the vaginal microilora in ovariectomized rats [J].Microb Ecol, 2008,55(4) : 751-759.
